EdgarLookup

Aligos Therapeutics, Inc. — 10-Q Filings

16 10-Q filings on record

This page lists all 10-Q filings submitted to the SEC by Aligos Therapeutics, Inc. (ALGS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Aligos Therapeutics, Inc. has filed 16 10-Q documents with the SEC since 2020. To view all SEC filings by Aligos Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 3 4 424B3 424B4 8-A12B 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DEFR14A DRS EFFECT PRE 14A S-1 S-1/A S-3 S-8 SC 13D SC 13D/A SC 13G SC 13G/A SC TO-C SC TO-I SC TO-I/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
10-Q 10-Q 0001193125-25-268203 Nov 6, 2025 Sep 30, 2025
10-Q 10-Q 0000950170-25-104042 Aug 6, 2025 Jun 30, 2025
10-Q 10-Q 0000950170-25-063983 May 6, 2025 Mar 31, 2025
10-Q 10-Q 0000950170-24-122371 Nov 6, 2024 Sep 30, 2024
10-Q 10-Q 0000950170-24-091828 Aug 6, 2024 Jun 30, 2024
10-Q 10-Q 0000950170-24-054497 May 7, 2024 Mar 31, 2024
10-Q 10-Q 0000950170-23-058256 Nov 2, 2023 Sep 30, 2023
10-Q 10-Q 0000950170-23-038045 Aug 3, 2023 Jun 30, 2023
10-Q 10-Q 0000950170-23-017890 May 4, 2023 Mar 31, 2023
10-Q 10-Q 0000950170-22-021248 Nov 2, 2022 Sep 30, 2022
10-Q 10-Q 0000950170-22-014815 Aug 4, 2022 Jun 30, 2022
10-Q 10-Q 0000950170-22-007407 May 4, 2022 Mar 31, 2022
10-Q 10-Q 0001564590-21-054514 Nov 4, 2021 Sep 30, 2021
10-Q 10-Q 0001564590-21-041653 Aug 5, 2021 Jun 30, 2021
10-Q 10-Q 0001564590-21-026071 May 10, 2021 Mar 31, 2021
10-Q 10-Q 0001193125-20-303749 Nov 25, 2020 Sep 30, 2020